Breaking News Instant updates and real-time market news.

NEOS

Neos Therapeutics

$2.69

-0.18 (-6.27%)

09:22
11/06/18
11/06
09:22
11/06/18
09:22

Neos Therapeutics 17.4M share Spot Secondary priced at $2.30

The deal range was $2.30-$2.50. Cantor Fitzgerald acted as sole book running manager for the offering.

  • 09

    Nov

  • 06

    Nov

NEOS Neos Therapeutics
$2.69

-0.18 (-6.27%)

04/24/18
EAMC
04/24/18
INITIATION
Target $15
EAMC
Buy
Neos Therapeutics initiated with a Buy at Empire
Empire initiated Neos Therapeutics with a Buy and $15 price target.
03/16/18
WELS
03/16/18
NO CHANGE
Target $14
WELS
Outperform
Neos Therapeutics continues to perform well, says Wells Fargo
Wells Fargo analyst David Maris says Neos Therapeutics is performing well and on an upward trajectory following its Q4 results. The analyst likes the progress the company is making and keeps an Outperform rating on the shares with a $14 price target.
01/30/18
BMOC
01/30/18
DOWNGRADE
Target $12
BMOC
Market Perform
Neos Therapeutics downgraded to Market Perform from Outperform at BMO Capital
BMO Capital analyst Gary Nachman downgraded Neos Therapeutics to Market Perform and lowered his price target for the shares to $12 from $14. The analyst views the stock's risk/reward as "appropriately balanced" following the rally over the last year. Nachman is also more cautious on the company's terminal value and would like to see additional pipeline advancements.
11/14/17
WELS
11/14/17
NO CHANGE
Target $12
WELS
Outperform
Pfizer ADHD drug supply shortage is positive for Neos, says Wells Fargo
Wells Fargo analyst David Maris says Pfizer (PFE) has sent a letter on physicians dated November 8th telling them of a supply shortage for its liquid and chewable methylphenidate ADHD products. Maris says Pfizer's product is a direct competitor of Neos' (NEOS) recently-launched Cotempla XR-ODT, adding Neos will benefit from having its primary competition in the alternative dose market facing a shortage. The analyst says Cotempla XR-ODT, launched in September, is off to a very strong start, keeping his Outperform rating with a $12 price target on Neos.

TODAY'S FREE FLY STORIES

WSM

Williams-Sonoma

$60.60

-1.16 (-1.88%)

06:38
11/16/18
11/16
06:38
11/16/18
06:38
Recommendations
Williams-Sonoma analyst commentary  »

Williams-Sonoma price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$143.86

-0.39 (-0.27%)

06:34
11/16/18
11/16
06:34
11/16/18
06:34
Periodicals
Facebook CEO says he was unaware of Definers Public Affairs hiring, BI reports »

Facebook CEO Mark…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

EMCI

EMC Insurance

$23.85

-0.07 (-0.29%)

06:33
11/16/18
11/16
06:33
11/16/18
06:33
Hot Stocks
EMCC proposes to acquire remaining shares of EMC Insurance for $30 per share »

Employers Mutual Casualty…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$143.86

-0.39 (-0.27%)

06:25
11/16/18
11/16
06:25
11/16/18
06:25
Periodicals
Facebook faces renewed criticism from Washington after NYT story, Recode says »

Facebook is facing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

FUJHY

Subaru

$0.00

(0.00%)

06:25
11/16/18
11/16
06:25
11/16/18
06:25
Downgrade
Subaru rating change  »

Subaru downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WSM

Williams-Sonoma

$60.60

-1.16 (-1.88%)

, RH

RH

$119.39

-4.73 (-3.81%)

06:24
11/16/18
11/16
06:24
11/16/18
06:24
Recommendations
Williams-Sonoma, RH analyst commentary  »

Williams-Sonoma price…

WSM

Williams-Sonoma

$60.60

-1.16 (-1.88%)

RH

RH

$119.39

-4.73 (-3.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MMTOF

Mitsubishi Motors

$0.00

(0.00%)

06:23
11/16/18
11/16
06:23
11/16/18
06:23
Upgrade
Mitsubishi Motors rating change  »

Mitsubishi Motors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$143.86

-0.39 (-0.27%)

, PUBGY

Publicis

$0.00

(0.00%)

06:22
11/16/18
11/16
06:22
11/16/18
06:22
Periodicals
Facebook lack of morals drawing ire from advertisers, New York Times reports »

Facebook (FB) is coming…

FB

Facebook

$143.86

-0.39 (-0.27%)

PUBGY

Publicis

$0.00

(0.00%)

WPP

WPP

$55.45

-0.65 (-1.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

EVKIF

Evonik

$0.00

(0.00%)

06:20
11/16/18
11/16
06:20
11/16/18
06:20
Downgrade
Evonik rating change  »

Evonik downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VLKAY

Volkswagen

$0.00

(0.00%)

06:16
11/16/18
11/16
06:16
11/16/18
06:16
Periodicals
Volkswagen CEO to assume responsibility for China business, Reuters reports »

Volkswagen CEO Herbert…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$202.65

5.43 (2.75%)

06:13
11/16/18
11/16
06:13
11/16/18
06:13
Recommendations
Nvidia analyst commentary  »

Nvidia price target cut…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 26

    Nov

  • 10

    Dec

YEXT

Yext

$17.44

0.35 (2.05%)

06:08
11/16/18
11/16
06:08
11/16/18
06:08
Initiation
Yext initiated  »

Yext initiated with a Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

PLUS

ePlus

06:07
11/16/18
11/16
06:07
11/16/18
06:07
Initiation
ePlus initiated  »

ePlus initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENR

Energizer

$51.44

-4.51 (-8.06%)

06:07
11/16/18
11/16
06:07
11/16/18
06:07
Downgrade
Energizer rating change  »

Energizer downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$143.86

-0.39 (-0.27%)

06:06
11/16/18
11/16
06:06
11/16/18
06:06
Periodicals
Zuckerberg says he's still the best person to run Facebook, BI reports »

CEO Mark Zuckerberg…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

TKPYY

Takeda Pharmaceutical

$0.00

(0.00%)

, SHPG

Shire

$178.98

-1.15 (-0.64%)

06:06
11/16/18
11/16
06:06
11/16/18
06:06
Periodicals
Takeda dissident shareholders make final push to stop Shire deal, FT reports »

A dissident group of…

TKPYY

Takeda Pharmaceutical

$0.00

(0.00%)

SHPG

Shire

$178.98

-1.15 (-0.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

  • 21

    Dec

SBRA

Sabra Health Care

$19.12

-0.52 (-2.65%)

06:06
11/16/18
11/16
06:06
11/16/18
06:06
Downgrade
Sabra Health Care rating change  »

Sabra Health Care…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OHI

Omega Healthcare

$34.34

-0.13 (-0.38%)

06:05
11/16/18
11/16
06:05
11/16/18
06:05
Upgrade
Omega Healthcare rating change  »

Omega Healthcare upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DSW

DSW

$25.39

-0.4 (-1.55%)

06:05
11/16/18
11/16
06:05
11/16/18
06:05
Upgrade
DSW rating change  »

DSW upgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BPMX

BioPharmX

$0.18

-0.0032 (-1.77%)

06:05
11/16/18
11/16
06:05
11/16/18
06:05
Hot Stocks
BioPharmX announces NYSE acceptance of plan to regain compliance »

BioPharmX announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$202.65

5.43 (2.75%)

06:05
11/16/18
11/16
06:05
11/16/18
06:05
Downgrade
Nvidia rating change  »

Nvidia downgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 26

    Nov

  • 10

    Dec

PBA

Pembina Pipeline

06:04
11/16/18
11/16
06:04
11/16/18
06:04
Upgrade
Pembina Pipeline rating change  »

Pembina Pipeline upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EOG

EOG Resources

06:04
11/16/18
11/16
06:04
11/16/18
06:04
Upgrade
EOG Resources rating change  »

EOG Resources upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AFI

Armstrong Flooring

$16.66

1.85 (12.49%)

06:03
11/16/18
11/16
06:03
11/16/18
06:03
Upgrade
Armstrong Flooring rating change  »

Armstrong Flooring…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LGF.A

Lionsgate

$20.52

0.595 (2.99%)

05:59
11/16/18
11/16
05:59
11/16/18
05:59
Upgrade
Lionsgate rating change  »

Lionsgate upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.